SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-18-008543
Filing Date
2018-04-20
Accepted
2018-04-20 13:05:08
Documents
5
Effectiveness Date
2018-04-20

Document Format Files

Seq Description Document Type Size
1 DEFA14A apvo-defa14a_20180601.htm DEFA14A 19152
2 GRAPHIC g2018042003364030917676.jpg GRAPHIC 93248
3 GRAPHIC g2018042003364028917675.jpg GRAPHIC 61522
4 GRAPHIC g2018042003364033017677.jpg GRAPHIC 26599
5 GRAPHIC g2018042003364034617678.jpg GRAPHIC 12200
  Complete submission text file 0001564590-18-008543.txt   287322
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37746 | Film No.: 18765790
SIC: 2834 Pharmaceutical Preparations